R Nightingale, F Carlin, J Meghji, K McMullen, D Evans, M M van der Zalm, M G Anthony, M Bittencourt, A Byrne, K du Preez, M Coetzee, C Feris, P Goussard, K Hirasen, J Bouwer, G Hoddinott, M A Huaman, G Inglis-Jassiem, O Ivanova, F Karmadwala, H S Schaaf, I Schoeman, J A Seddon, T Sineke, R Solomons, M Thiart, R van Toorn, P I Fujiwara, K Romanowski, S Marais, A C Hesseling, J Johnston, B Allwood, J C Muhwa, K Mortimer
TB affects around 10.6 million people each year and there are now around 155 million TB survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In 2019, representatives of TB affected communities attending the '1st International Post-Tuberculosis Symposium´ called for the development of clinical guidance on these issues. This clinical statement on post-TB health and wellbeing responds to this call and builds on the work of the symposium, which brought together TB survivors, healthcare professionals and researchers...
April 1, 2023: International Journal of Tuberculosis and Lung Disease